# FDA Inspection 1169545 - Opocrin SPA - February 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/opocrin-spa/2ee96436-2b50-4dff-93a6-893f961d00fa
Source feed: FDA_Inspections

> FDA Inspection 1169545 for Opocrin SPA on February 25, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169545
- Company Name: Opocrin SPA
- Inspection Date: 2022-02-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1092538 - 2017-09-29](https://www.keypedia.com/records/fda_inspections/opocrin-spa/c740716d-0b2e-40c3-b52c-a90de2b20025)
- [FDA Inspection 970807 - 2016-05-06](https://www.keypedia.com/records/fda_inspections/opocrin-spa/39bc51a8-58f1-411f-bfab-244c92988c00)

Company: https://www.keypedia.com/companies/opocrin-spa/b8245081-94fa-41f2-826d-aa705b32a704

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c